OCULAR THERAPEUTIX, INC (OCUL) Nonoperating Income (Expense) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Ocular Therapeutix, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2024.
  • Ocular Therapeutix, Inc Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$33.2 M, a 328% decline year-over-year.
  • Ocular Therapeutix, Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$23.8 M, a 337% decline year-over-year.
  • Ocular Therapeutix, Inc annual Nonoperating Income (Expense) for 2023 was $1.65 M, a 78.4% decline from 2022.
  • Ocular Therapeutix, Inc annual Nonoperating Income (Expense) for 2022 was $7.62 M, a 89.3% decline from 2021.
  • Ocular Therapeutix, Inc annual Nonoperating Income (Expense) for 2021 was $71.5 M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$23.8 M -$33.2 M -$25.5 M -328% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.65 M -$9.17 M -$13 M -340% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $14.6 M $18.7 M +$21.3 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$6.71 M -$112 K -$1.26 M -110% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 -$5.44 M -$7.77 M -$13.1 M -247% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $7.62 M $3.82 M -$10.4 M -73.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $18 M -$2.64 M -$24.8 M -112% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $42.8 M $1.15 M -$10.6 M -90.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $53.4 M $5.29 M -$18.1 M -77.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $71.5 M $14.2 M +$85.5 M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 -$14 M $22.2 M +$20.1 M +976% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$34.1 M $11.8 M +$30.4 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$64.5 M $23.3 M +$28.2 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$92.8 M -$71.3 M -$66.7 M -1444% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 -$26.1 M $2.06 M -$2.3 M -52.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$23.8 M -$18.7 M -$15.8 M -555% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$8 M -$4.9 M -$7.43 M -293% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$570 K -$4.62 M -$4.5 M -3879% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $3.93 M $4.37 M +$4.56 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$630 K -$2.85 M -$2.61 M -1089% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $1.98 M $2.53 M +$2.84 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$860 K -$116 K +$270 K +69.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$1.13 M -$194 K +$177 K +47.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$1.31 M -$240 K +$115 K +32.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$1.42 M -$310 K +$41 K +11.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$1.46 M -$386 K -$36 K -10.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 -$1.43 M -$371 K -$13 K -3.63% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$1.41 M -$355 K -$17 K -5.03% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$1.4 M -$351 K -$20 K -6.04% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$1.38 M -$350 K +$12 K +3.32% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 -$1.39 M -$358 K -$8 K -2.29% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$1.38 M -$338 K +$36 K +9.63% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$1.42 M -$331 K +$134 K +28.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 -$1.55 M -$362 K +$45 K +11.1% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$1.6 M -$350 K +$168 K +32.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$1.76 M -$374 K +$72 K +16.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$1.84 M -$465 K -$282 K -154% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$1.55 M -$407 K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$518 K -$431 K -495% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$446 K -$345 K -342% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$183 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2013 -$87 K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$101 K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.